- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Journal Club - Dopamine role in social cognition and recognizing emotions - Video
Overview
Dopamine which is a type of monoamine neurotransmitter and is famous for its role in reward, movement, memory and motivation is also found to be involved in recognizing emotions.
People with disrupted dopamine levels, like in Parkinson's disease and schizophrenia, often struggle with aspects of social cognition. Yet the link between dopamine and specific social behaviors remained elusive, in part due to mixed results from studies that did not account for individual differences in dopamine levels.
In a study by Schuster et al., healthy participants took haloperidol — a dopamine receptor inhibitor — on one day and a placebo pill on another before completing an emotion recognition task.
They assessed videos of people expressing an emotion through their posture and gait (thatis, slow movements for sadness, quick, jerky movements for anger). The researchers also indirectly measured each person's baseline dopamine levels by testing their working memory.
The effects of haloperidol varied in each person depending on their baseline dopamine levels. In people with low dopamine, the drug increased their ability to recognize emotions, while in people with high dopamine, the drug impaired their ability. Future work will examine how changes in dopamine levels in disorders like Parkinson's disease contribute to social cognition impairments.